AMP Blog

A study published in The Journal of Molecular Diagnostics emphasizes the need to understand the function of TPMT∗8 to ensure testing to predict thiopurine tolerance is effective, regardless of ancestry.

A low-cost CRISPR-based paper strip test distinguishes between influenza types and can be reprogrammed to recognize different viruses including the H5N1 bird flu virus. The work was reported in The Journal of Molecular Diagnostics.

A streamlined urine DNA test more accurately detects primary bladder cancer, reducing the need for more invasive cystoscopy, reports The Journal of Molecular Diagnostics.

A new analysis method, reported in The Journal of Molecular Diagnostics, can detect pathogens in blood samples faster and more accurately than blood cultures. It is also less likely to generate false positives compared to other emerging DNA detection-based technologies, such as next generation sequencing. 

On July 27, 2023, molecular professionals from around the United States met with the offices of their elected representatives to express opposition to the Patent Eligibility Restoration Act of 2023. This concerning legislation would reverse a unanimous 2013 Supreme Court decision that has led to a decade of unprecedented scientific innovations and aided the U.S. testing response to the COVID-19 pandemic.

Samuel Caughron and Timothy J. O'Leary, members of the AMP COVID Response Steering Committee, explore different types of tests available to consumers as the fall flu season approaches.

Karen L. Kaul, MD, PhD, a member of the AMP COVID Response Steering Committee, provides an assessment on how in-system labs were instrumental in keeping institutions functioning and solvent during the pandemic.

Donna M. Wolk, PhD, Chair of the AMP Infectious Diseases Subdivision, shares a quick checklist for organizations looking to contract a clinical laboratory for COVID-19 screening testing as part of its reopening strategy.